Literature DB >> 27861263

Mechanisms of graft rejection after lung transplantation.

Hsi-Min Hsiao1, Davide Scozzi, Jason M Gauthier, Daniel Kreisel.   

Abstract

PURPOSE OF REVIEW: To date, outcomes after lung transplantation are far worse than after transplantation of other solid organs. New insights into mechanisms that contribute to graft rejection and tolerance after lung transplantation remain of great interest. This review examines the recent literature on the role of innate and adaptive immunity in shaping the fate of lung grafts. RECENT
FINDINGS: Innate and adaptive immune cells orchestrate allograft rejection after transplantation. Innate immune cells such as neutrophils are recruited to the lung graft early after reperfusion and subsequently promote allograft rejection. Although it is widely recognized that CD4 T lymphocytes in concert with CD8 T cells promote graft rejection, regulatory Foxp3 CD4 T, central memory CD8 T cells, and natural killer cells can facilitate tolerance.
SUMMARY: This review highlights interactions between innate and adaptive immune pathways and how they contribute to lung allograft rejection. These findings lay a foundation for the design of new therapeutic strategies that target both innate and adaptive immune responses.

Entities:  

Mesh:

Year:  2017        PMID: 27861263      PMCID: PMC5443682          DOI: 10.1097/MOT.0000000000000371

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  74 in total

1.  Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection.

Authors:  J Trambley; A W Bingaman; A Lin; E T Elwood; S Y Waitze; J Ha; M M Durham; M Corbascio; S R Cowan; T C Pearson; C P Larsen
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Lung and Heart-Lung Transplantation Report--2015; Focus Theme: Early Graft Failure.

Authors:  Roger D Yusen; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Anne I Dipchand; Samuel B Goldfarb; Bronwyn J Levvey; Lars H Lund; Bruno Meiser; Joseph W Rossano; Josef Stehlik
Journal:  J Heart Lung Transplant       Date:  2015-09-03       Impact factor: 10.247

3.  The significance of a single episode of minimal acute rejection after lung transplantation.

Authors:  Ramsey R Hachem; Anthony P Khalifah; Murali M Chakinala; Roger D Yusen; Aviva A Aloush; Thalachallour Mohanakumar; G Alexander Patterson; Elbert P Trulock; Michael J Walter
Journal:  Transplantation       Date:  2005-11-27       Impact factor: 4.939

Review 4.  Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy.

Authors:  Anna L Taylor; Christopher J E Watson; J Andrew Bradley
Journal:  Crit Rev Oncol Hematol       Date:  2005-10       Impact factor: 6.312

5.  Mast cells contribute to altered vascular reactivity and ischemia-reperfusion injury following cerium oxide nanoparticle instillation.

Authors:  Christopher J Wingard; Dianne M Walters; Brook L Cathey; Susana C Hilderbrand; Pranita Katwa; Sijie Lin; Pu Chun Ke; Ramakrishna Podila; Apparao Rao; Robert M Lust; Jared M Brown
Journal:  Nanotoxicology       Date:  2010-11-03       Impact factor: 5.913

6.  Mast cells are essential intermediaries in regulatory T-cell tolerance.

Authors:  Li-Fan Lu; Evan F Lind; David C Gondek; Kathy A Bennett; Michael W Gleeson; Karina Pino-Lagos; Zachary A Scott; Anthony J Coyle; Jennifer L Reed; Jacques Van Snick; Terry B Strom; Xin Xiao Zheng; Randolph J Noelle
Journal:  Nature       Date:  2006-08-20       Impact factor: 49.962

7.  HMGB1 contributes to kidney ischemia reperfusion injury.

Authors:  Huiling Wu; Jin Ma; Peng Wang; Theresa M Corpuz; Usha Panchapakesan; Kate R Wyburn; Steven J Chadban
Journal:  J Am Soc Nephrol       Date:  2010-09-16       Impact factor: 10.121

8.  Neutralizing IL-17 prevents obliterative bronchiolitis in murine orthotopic lung transplantation.

Authors:  L Fan; H L Benson; R Vittal; E A Mickler; R Presson; A Jo Fisher; O W Cummings; K M Heidler; M R Keller; W J Burlingham; D S Wilkes
Journal:  Am J Transplant       Date:  2011-04-19       Impact factor: 8.086

9.  Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response.

Authors:  Nan Zhang; Bernd Schröppel; Girdhari Lal; Claudia Jakubzick; Xia Mao; Dan Chen; Na Yin; Rolf Jessberger; Jordi C Ochando; Yaozhong Ding; Jonathan S Bromberg
Journal:  Immunity       Date:  2009-03-20       Impact factor: 31.745

10.  Postischemic vascular permeability requires both TLR-2 and TLR-4, but only TLR-2 mediates the transendothelial migration of leukocytes.

Authors:  Alexander Georg Khandoga; Andrej Khandoga; Hans-Joachim Anders; Fritz Krombach
Journal:  Shock       Date:  2009-06       Impact factor: 3.454

View more
  6 in total

1.  Screening gene signatures for clinical response subtypes of lung transplantation.

Authors:  Yu-Hang Zhang; Zhan Dong Li; Tao Zeng; Lei Chen; Tao Huang; Yu-Dong Cai
Journal:  Mol Genet Genomics       Date:  2022-07-03       Impact factor: 2.980

2.  Intermittent Exposure of Hypercapnia Suppresses Allograft Rejection via Induction of Treg Differentiation and Inhibition of Neutrophil Accumulation.

Authors:  Yuan-Sheng Tzeng; Yi-Jen Peng; Shih-En Tang; Kun-Lun Huang; Shi-Jye Chu; Shu-Yu Wu; Chia-Pi Cheng
Journal:  Biomedicines       Date:  2022-04-01

3.  Impact of Regulatory T Cells on Innate Immune Cells in a Pre-Sensitized Heart Transplant Model.

Authors:  Weihua Gong; Baoqing Liu; Juntao Chen; Chen Liu; Zhonghua Shen
Journal:  Ann Transplant       Date:  2018-04-13       Impact factor: 1.530

4.  Effect of Immunosuppression on Target Blood Immune Cells Within 1 Year After Lung Transplantation: Influence of Age on T Lymphocytes.

Authors:  Benjamin Coiffard; Matthieu Pelardy; Anderson D Loundou; Corine Nicolino-Brunet; Pascal Alexandre Thomas; Laurent Papazian; Françoise Dignat-George; Martine Reynaud-Gaubert
Journal:  Ann Transplant       Date:  2018-01-05       Impact factor: 1.530

Review 5.  Role of Mast Cells and Type 2 Innate Lymphoid (ILC2) Cells in Lung Transplantation.

Authors:  Esmaeil Mortaz; Saeede Amani; Sharon Mumby; Ian M Adcock; Mehrnaz Movassaghi; Jelle Folkerts; Johan Garssen; Gert Folkerts
Journal:  J Immunol Res       Date:  2018-10-30       Impact factor: 4.818

6.  FK506 induces lung lymphatic endothelial cell senescence and downregulates LYVE-1 expression, with associated decreased hyaluronan uptake.

Authors:  Shikshya Shrestha; Woohyun Cho; Benjamin Stump; Jewel Imani; Anthony M Lamattina; Pierce H Louis; James Pazzanese; Ivan O Rosas; Gary Visner; Mark A Perrella; Souheil El-Chemaly
Journal:  Mol Med       Date:  2020-07-31       Impact factor: 6.376

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.